US FDA To Bring Back Routine Domestic Surveillance Inspection
By highlighting the decreasing novel corona virus cases in the United States, a spokesperson for the Food and Drug Administration (FDA) of the United States said, the agency is going to be resuming the operations of the domestic surveillance inspection in the month of February 2022. The Office of Regulatory Affairs of the US FDA […]
Continue Reading